NanoString Technologies to Release Second Quarter 2014 Financial...
NanoString Technologies, Inc. , a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2014 second quarter financial results after the close of trading on Tuesday, August 5, 2014.
Is NanoString The Next Illumina In Cancer Diagnostics?
NanoString Technologies has transformed from a company focused on research laboratories to a company focused on clinical laboratories, which provides significant growth opportunities.
NanoString Technologies to Participate in the JMP Securities Healthcare Conference 2014
NanoString Technologies, Inc. , today announced that its management is scheduled to participate in the JMP Securities Healthcare Conference 2014 in New York.
NanoString Technologies to Participate in the Jefferies 2014 Global Healthcare Conference
NanoString Technologies, Inc. , today announced that its management is scheduled to participate in the Jefferies 2014 Global Healthcare Conference in New York.
Nanostring Technologies Inc. Files SEC Form 8-K, Current Report
There were 3 documents filed with this form. The 98109, 206-378-6266. Our editors provided additional information about Form 8-K: This is the "current report" that is used to report the occurrence of any material events or corporate changes which are of importance to investors or security holders and previously have not been reported by the ... (more)